August 17, 2018
Guardian Pharmacy Services is recalling 60 syringes of cefazolin 2 gm/20 mL because of sterility concerns, according to the August 15, 2018, US Food and Drug Administration (FDA) Enforcement Report.
The 20-mL syringes were distributed in Texas and are from lots 58758, 58760, 58756, 59095:42, 59093:42, and 59091:42.
The recall was voluntarily initiated by Guardian Pharmacy Services May 17, 2018. On August 8, 2018, the FDA designated the recall Class II. The classification suggests use of the product could cause temporary or medically reversible adverse health consequences. Although the likelihood is remote, a possibility of serious harm also exists.
Cefazolin is a prescription cephalosporin antibiotic injection used to treat or prevent a broad range of bacterial infections.
For more Pharmacy Learning Network articles, visit the homepage
To learn about Pharmacy Learning Network Live meetings, click here